Research & Development World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE

Managing Disease Spread Through Accessible Modeling

By DOE/Los Alamos National Laboratory | April 26, 2017

The research draws on Los Alamos’ expertise in computational modeling and health sciences and contributes to the Laboratory’s national security mission by protecting against biological threats. Infectious diseases are a leading cause of death globally. Source: LANL

 A new computer modeling study from Los Alamos National Laboratory is aimed at making epidemiological models more accessible and useful for public-health collaborators and improving disease-related decision making.

“In a real-world outbreak, the time is often too short and the data too limited to build a really accurate model to map disease progression or guide public-health decisions,” said Ashlynn R. Daughton, a graduate research assistant at Los Alamos and doctoral student at University of Colorado, Boulder. She is lead author on a paper out last week in Scientific Reports, a Nature journal. “Our aim is to use existing models with low computational requirements first to explore disease-control measures and second to develop a platform for public-health collaborators to use and provide feedback on models,” she said.

The research draws on Los Alamos’ expertise in computational modeling and health sciences and contributes to the Laboratory’s national security mission by protecting against biological threats. Infectious diseases are a leading cause of death globally. Decisions surrounding how to control an infectious disease outbreak currently rely on a highly subjective process that involves both surveillance and expert opinion. Epidemiological modeling can fill gaps in the decision-making process, she says, by using available data to provide quantitative estimates of outbreak trajectories–determining where the infection is going, and how fast, so medical supplies and staff can be deployed for maximum effect. But if the tool requires unavailable data or overwhelms the capabilities of the health system, it won’t be operationally useful.

Collaboration between the modeling community and public-health policy community enables effective deployment, but the modeling resources need to be connected more strongly with the health community. Such collaboration is rare, as Daughton describes it, resulting in a scarcity of models that truly meet the needs of the public-health community.

Simple, traditional models group people into categories based on their disease status (for example, SIR for Susceptible, Infected or Recovered). “For this initial work, we use a SIR model, modified to include a control measure, to explore many possible disease progression paths. The SIR model was chosen because it is the simplest and requires minimal computational resources,” the paper notes.

Other models are called agent-based, meaning they identify agents, often akin to an “individual,” and map each agent’s potential interactions during a day (for example, an individual might go to school, go to work, and interact with other members of the household). The model then extrapolates how each interaction could spread the disease. Because these are high-resolution models requiring significant expertise and computing power, as well as large quantities of data, they require resources beyond the reach of an average health department.

For this study, using the simpler SIR model, the team explored outbreaks of measles, norovirus and influenza to show the feasibility of its use and describe a research agenda to further promote interactions between decision makers and the modeling community.

“Unlike standard epidemiological models that are disease and location specific and not transferrable or generalizable, this model is disease and location agnostic and can be used at a much higher level for planning purposes regardless of the specific control measure,” said Alina Deshpande, group leader of the Biosecurity and Public Health group at Los Alamos and principal investigator on the project.

Overall, the team determined, there is a clear need in the field to better understand outbreak parameters, underlying model assumptions, and the ways that these apply to real-world scenarios.

The authors conclude, “We thus propose thoughtful validation of SIR models as an important next step. Such a validation would accomplish several things. It would (1) validate the counterfactual approach, (2) provide additional data to describe when compartmental models are appropriate approximations of real world outbreaks and (3) provide data to describe situations where the compartmental models do not match real world outbreaks and should not be used for decision support.”

Related Articles Read More >

How Lantern Med Digital is helping build the digital layer of Costa Rica’s medtech boom
Norstella launches Atlas, a biopharma agentic platform that can ‘train you’
How a Duke-led HPC method brought cell-scale cancer simulation to a single cloud node 
As AI floods drug discovery with designs, Twist uses DNA chips to tackle the wet-lab bottleneck
rd newsletter
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, trends, and strategies in Research & Development.

R&D World Digital Issues

Fall 2025 issue

Browse the most current issue of R&D World and back issues in an easy to use high quality format. Clip, share and download with the leading R&D magazine today.

R&D 100 Awards
Research & Development World
  • Subscribe to R&D World Magazine
  • Sign up for R&D World’s newsletter
  • Contact Us
  • About Us
  • Drug Discovery & Development
  • Pharmaceutical Processing
  • Global Funding Forecast

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search R&D World

  • R&D World Home
  • Topics
    • Aerospace
    • Automotive
    • Biotech
    • Careers
    • Chemistry
    • Environment
    • Energy
    • Life Science
    • Material Science
    • R&D Management
    • Physics
  • Technology
    • 3D Printing
    • A.I./Robotics
    • Software
    • Battery Technology
    • Controlled Environments
      • Cleanrooms
      • Graphene
      • Lasers
      • Regulations/Standards
      • Sensors
    • Imaging
    • Nanotechnology
    • Scientific Computing
      • Big Data
      • HPC/Supercomputing
      • Informatics
      • Security
    • Semiconductors
  • R&D Market Pulse
  • R&D 100
    • 2026 R&D 100 Award Winners
    • 2026 Professional Award Winners
    • 2026 Special Recognition Winners
    • R&D 100 Awards Event
    • R&D 100 Submissions
    • Winner Archive
  • Resources
    • Research Reports
    • Digital Issues
    • Educational Assets
    • Subscribe
    • Video
    • Webinars
    • PharmSci360
    • Content submission guidelines for R&D World
  • Global Funding Forecast
  • Top Labs
  • Advertise
  • SUBSCRIBE